Breaking News

MilliporeSigma Expands Biodevelopment Centers

New facilities in NA and China along with full single-use GMP facility in France to accelerate development of biologics

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

MilliporeSigma has expanded its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing products, manufacturing capabilities and technological expertise. The expansion, which includes the opening of two new process development centers in the U.S. and China, follows the commercial success of MilliporeSigma’s biodevelopment center in Martillac, France. The two new units will be located in close proximity to customers in the Shanghai ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters